Vergoeding 2017-2021 voor ATC-subgroep A10BB : Sulfonylureumderivaten
- Raming voor de totale Zvw-populatie
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| A10BB01 Glibenclamide | 50.874 | 51.294 | 56.452 | 63.453 | 12.882 |
| A10BB03 Tolbutamide | 1.361.400 | 1.251.000 | 1.437.800 | 1.410.600 | 1.250.300 |
| A10BB09 Gliclazide (Diamicron ®) | 4.250.400 | 5.425.000 | 6.397.300 | 6.694.300 | 8.657.000 |
| A10BB12 Glimepiride (Amaryl ®) | 872.180 | 764.600 | 768.410 | 739.740 | 675.780 |
| Totaal | 6.534.854 | 7.491.894 | 8.659.962 | 8.908.093 | 10.595.962 |